PriceTargets.com logo

Akumin - AKU Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: C$0.00
  • Forecasted Upside: NaN
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
C$0.00 As of 02/2/2024 12:59 AM ET
+0 (0.00%)

This chart shows the closing price for AKU by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Akumin Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for AKU and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for AKU

Analyst Price Target is C$0.00
This price target is based on 1 analysts offering 12 month price targets for Akumin in the last 3 months. The average price target is C$0.00, with a high forecast of C$0.00 and a low forecast of C$10,000,000.00. The average price target represents a NaN upside from the last price of C$0.00.

This chart shows the closing price for AKU for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Hold

The current consensus among 1 polled investment analysts is to hold stock in Akumin. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
11/1/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
1/30/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
4/30/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
7/29/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
10/27/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
1/25/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
3/25/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
4/24/2024

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
10/24/2023Clarus SecuritiesDowngradeBuy ➝ Hold
8/15/2022Clarus SecuritiesReiterated RatingBuyC$6.75
3/21/2022Clarus SecuritiesInitiated CoverageBuyC$6.50
2/1/2022National Bank FinancialDowngradeSector Perform Market Weight ➝ Underperform Market Weight
11/16/2021Clarus SecuritiesReiterated RatingBuyC$7.50
11/8/2021National Bank FinancialReiterated RatingSector Perform Market Weight
9/8/2021Clarus SecuritiesReiterated RatingBuyC$8.00
6/28/2021National Bank FinancialBoost TargetSector PerformC$4.30
2/9/2021Clarus SecuritiesReiterated RatingBuy
10/21/2020National Bank FinancialBoost TargetSector PerformC$2.50 ➝ C$3.25
4/1/2020National Bank FinancialDowngradeOutperform Market Weight ➝ Sector Perform Market Weight
3/5/2020National Bank FinancialLower TargetC$5.75 ➝ C$5.00
(Data available from 4/24/2019 forward)

News Sentiment Rating

0.49 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/27/2023
  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
Mentions as of
10/27/2023
  • 0 very positive mentions
  • 1 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
11/26/2023
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/26/2023
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/25/2024
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/24/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/25/2024
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/24/2024

Current Sentiment

  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

  • No very positive mentions tracked during this time.
Akumin logo
Akumin Inc. provides outpatient diagnostic imaging services in the United States. It operates in two segments, Radiology and Oncology. The company offers various medical imaging services, including magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other diagnostic and interventional radiology procedures through owned and/or operated imaging locations. It provides outpatient radiology, and oncology services and solutions to hospitals and health systems across 48 states. Akumin Inc. was founded in 2015 and is headquartered in Plantation, Florida. On October 22, 2023, Akumin Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Southern District of Texas.
Read More

Today's Range

Now: N/A

50 Day Range

MA: C$0.48
Low: C$0.40
High: C$0.53

52 Week Range

Now: N/A

Volume

12,903 shs

Average Volume

7,202 shs

Market Capitalization

C$37.20 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.15

Frequently Asked Questions

What sell-side analysts currently cover shares of Akumin?

The following Wall Street analysts have issued stock ratings on Akumin in the last year: Clarus Securities.
View the latest analyst ratings for AKU.

What is the current price target for Akumin?

0 Wall Street analysts have set twelve-month price targets for Akumin in the last year. has the lowest price target set, forecasting a price of C$10,000,000.00 for Akumin in the next year.
View the latest price targets for AKU.

What is the current consensus analyst rating for Akumin?

Akumin currently has 1 hold rating from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in AKU, but not buy more shares or sell existing shares.
View the latest ratings for AKU.

What other companies compete with Akumin?

Other companies that are similar to Akumin include GeneNews, LED Medical Diagnostics, LexaGene, Spectral Medical and Viridium Pacific Group. Learn More about companies similar to Akumin.

How do I contact Akumin's investor relations team?

Akumin's physical mailing address is 8300 West Sunrise Boulevard, Plantation, FL 33322, United States. The company's listed phone number is 416-613-1391. The official website for Akumin is www.akumin.com. Learn More about contacing Akumin investor relations.